Richard Anthony Selected Research

Richard Anthony Research Topics

7	Tuberculosis (Tuberculoses) 01/2020 - 07/2014
2	Peripheral Arterial Disease 12/2006 - 04/2006
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2021
1	Infections 01/2019
1	Extensively Drug-Resistant Tuberculosis 01/2019
1	Pulmonary Tuberculosis 11/2018
1	Hepatic Encephalopathy 01/2017
1	Leprosy (Hansen's Disease) 06/2016
1	Extrapulmonary Tuberculosis 10/2015
1	Lung Diseases (Lung Disease) 07/2014
1	Pain (Aches) 05/2007
1	Chronic Limb-Threatening Ischemia 05/2007
1	Ischemia 04/2006

3	Rifampin (Rifampicin)FDA LinkGeneric 01/2021 - 06/2016
3	Pharmaceutical PreparationsIBA 11/2018 - 10/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 11/2018
2	Biomarkers (Surrogate Marker)IBA 11/2018 - 05/2016
2	Alprostadil (Muse)FDA LinkGeneric 05/2007 - 04/2006
2	EcraprostIBA 05/2007 - 04/2006
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2020
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 01/2019
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2019
1	Fetal Proteins (Fetoprotein)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 07/2014
1	4- bromo- 6- (3- (4- chlorophenyl)propoxy)- 5- (3- pyridylmethylamino)- 3(2H)- pyridazinone hydrochlorideIBA 12/2006
1	Phosphodiesterase InhibitorsIBA 12/2006
1	ProstaglandinsIBA 04/2006
1	EicosanoidsIBA 04/2006
1	LipidsIBA 04/2006
1	ProdrugsIBA 04/2006

3	Therapeutics 10/2017 - 04/2006
1	Retreatment 10/2015
1	Surgical Amputation (Amputations) 05/2007